Rhenman & Partners strengthens its investment team with a biopharma analyst
Rhenman & Partners hires Amennai Beyeen as biopharma analyst. Amennai will have a particular focus on biopharma companies and the development of new drugs and treatments. He will be working closely with all colleagues of Rhenman & Partners’ five-person investment team, all based in the firm’s Stockholm office. Most recently Amennai comes from Novartis, where […]
Summary – November 2022
Rate hikes and their impact on economic growth and earnings were the factors that defined November. The aggressive actions of central banks so far this year have probably influenced capital markets more than anything else, including the war in Ukraine. Having been caught wrongfooted by persistently high inflation numbers, the Federal Reserve and its counterparties […]
Summary – October 2022
Following a poor September, capital markets experienced a strong October. The US Dow Jones Index posted its best October-month ever. Inflation numbers and thus interest rate hikes by central banks continued to take center stage. Fears that aggressive hikes would lead to a recession were mitigated by strong labor statistics, especially in the US. Value […]
Teresa Isele to be the new CEO of Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB appoints Teresa Isele as new CEO. Co-founder and current CEO Göran Nordström retires at the age of 69. Most recently Teresa comes from the role as CEO at Swedsec, which provides a licensing system for employees within the Swedish financial services industry. Teresa has previously held roles as acting […]
Rhenman & Partners winner of Refinitiv Lipper Fund Awards Nordics
At this year’s prestigous Refinitiv Lipper Nordics Fund Awards Rhenman & Partners was awarded named the winner in the catergory ”Alternative Long/Short Equity Global ” over a three year period.
EUROPEAN FUND MANAGER INSIGHTS 2021 – Specialist managers in a favourable position
Read article
Digital Care is Now Investable-HedgeNordic
Stockholm (HedgeNordic) – Whereas some industries such as retail or banking are almost unrecognizable from a decade or two ago due to digitalization, healthcare has been lagging behind other industries in the adoption of technologies. The Covid-19 pandemic has served as a big impetus for the digital transformation of healthcare. Read more
The Best Performers of 2019 -HedgeNordic
By EUGENIU GUZUN 23/01/2020 Stockholm (HedgeNordic) – In 2019, Nordic hedge funds had their best year in the past five years after the industry endured the second-worst year on record in 2018. The Nordic Hedge Index, which currently includes 160 funds, gained 5.3 percent last year, reflecting the aggregate performance of both up-and-running hedge funds […]
Best performing hedge fund in Europe- Article in Financial Times
Rhenman Healthcare Equity L/S claims the top position in Financial Times list of top performing Europe-based hedge funds of $100m or more over a 5-year period with an annualised net return of 27.12%. ww.ft.com/content/4bae25fe-7f87-11e8-bc55-50daf11b720d